Early initiation of inhaled corticosteroids does not decrease acute chest syndrome morbidity in pediatric patients with sickle cell disease.

Authors

Alexis Leonard
Nihal Godiwala
Nicole Herrera
Robert McCarter, George Washington University
Matthew Sharron
Emily Riehm Meier, George Washington UniversityFollow

Document Type

Journal Article

Publication Date

3-7-2018

Journal

Blood Cells, Molecules & Diseases

DOI

10.1016/j.bcmd.2018.03.001

APA Citation

Leonard, A., Godiwala, N., Herrera, N., McCarter, R., Sharron, M., & Meier, E. (2018). Early initiation of inhaled corticosteroids does not decrease acute chest syndrome morbidity in pediatric patients with sickle cell disease.. Blood Cells, Molecules & Diseases, (). http://dx.doi.org/10.1016/j.bcmd.2018.03.001

Peer Reviewed

1